AMRX Sale Disclosure
Daly Jason B. · SEC Form 4 · Filed Aug 13, 2026
Sale
Calculated transaction value
$3.65M
Daly Jason B. EVP, Chief Legal Officer
AMRX
Transaction date
Aug 12, 2026
Public filing date
Aug 13, 2026
Filing lag
Filed 1 day later
AMRX daily price context
Close on/before transaction
$17.66
Aug 12, 2026
Close before public filing
$17.66
Aug 12, 2026
Return since public filing
-3.68%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 210,000 shares @ $17.4
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-056754
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$3.77M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. AMRX Current | Sale | Aug 12, 2026 | $3.65M |
| Amneal Pharmaceuticals, Inc. AMRX | Sale | Aug 11, 2026 | $117.05K |